Phenotype, Genotype & Biomarkers in ALS and Related Disorders
This research wants to improve our understanding of Amyotrophic Lateral Sclerosis (ALS) and related conditions like Frontotemporal Dementia (FTD), Primary Lateral Sclerosis (PLS), Hereditary Spastic Paraplegia (HSP), and Progressive Muscular Atrophy (PMA). The study will look at how symptoms appear (phenotype), what genetic factors might be involved (genotype), and identify "biomarkers." Biomarkers are special signs in the body that can help us understand diseases better and track how treatments are working. By gathering information from people affected by these conditions and their close family members, scientists hope to develop better tools for creating new therapies in the future.
At a glance
What is this study about?
This study is about understanding a group of brain and nerve conditions, including Amyotrophic Lateral Sclerosis, often called ALS or Motor Neurone Disease. It also covers related conditions like Frontotemporal Dementia, which affects memory and behaviour, and Primary Lateral Sclerosis, Hereditary Spastic Paraplegia, and Progressive Muscular Atrophy, which cause muscle weakness and stiffness.
The main goals are to find out more about how these different conditions show up in people (their symptoms) and what genetic factors might be involved. Researchers will also be looking for "biomarkers." Think of biomarkers as clues in your body, like certain proteins or chemicals, that can tell doctors more about a disease or how it's changing. Finding good biomarkers is really important because they can help develop new treatments and allow doctors to see if those treatments are working.
By carefully studying these conditions and their genetic links, and by identifying these body clues, the researchers hope to lay the groundwork for developing more effective therapies. This kind of research is vital for improving the lives of people living with these challenging conditions.
Key takeaways
- This study aims to understand ALS and related conditions more deeply.
- Researchers will explore symptoms, genetics, and 'biomarkers'.
- It involves regular check-ups and providing biological samples (blood, urine, spinal fluid).
- Both patients and their close family members can participate.
- The goal is to help develop better treatments in the future.
- You won't receive a specific new treatment from this study.
Who may be eligible?
This study is looking for volunteers who have received a medical diagnosis of ALS, Frontotemporal Dementia (FTD), Primary Lateral Sclerosis (PLS), Hereditary Spastic Paraplegia (HSP), Progressive Muscular Atrophy (PMA), or Multisystem Proteinopathy (MSP). This includes both people whose condition runs in the family and those whose condition does not appear to be inherited.
Close family members of someone already taking part in the study are also welcome to join. Everyone involved must be able and willing to follow the study's instructions and attend appointments.
However, if you are in the very late stages of your illness, you might not be able to participate. Also, if you have other serious health problems that could make it difficult to understand the study results, or if they would stop you from taking part safely and fully, you might not be eligible.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have a diagnosis of ALS, FTD, PLS, HSP, PMA, or MSP?
- Am I a close family member of someone already diagnosed with these conditions?
- Am I able and willing to attend appointments and follow study instructions?
- Am I not in the very late stages of my illness?
- Do I have any other major health issues that might prevent me from safely taking part?
What does participation involve?
If you decide to join this study, you will be asked to attend regular appointments over a period of time. During these visits, the study team will carry out standard checks and evaluations to understand how your condition is progressing. You will also be asked to provide biological samples, such as blood, urine, and a sample of spinal fluid (CSF). Family members who join might be asked for blood samples to help with genetic research. The study does not involve taking any new medications or treatments.
Potential risks and benefits
Locations (15)
- Stanford UniversityVerified postcodePalo Alto, United States
- University of California San Diego (UCSD)Verified postcodeSan Diego, United States
- California Pacific Medical Center (CPMC)Verified postcodeSan Francisco, United States
- University of MiamiVerified postcodeMiami, United States
- University of IowaVerified postcodeIowa City, United States
- Kansas University Medical Center (KUMC)Verified postcodeKansas City, United States
- Twin Cities ALS Research ConsortiumVerified postcodeMinneapolis, United States
- Wake Forest UniversityVerified postcodeWinston-Salem, United States
- Cleveland ClinicVerified postcodeCleveland, United States
- University of PennsylvaniaVerified postcodePhiladelphia, United States
- University of Texas Southwestern (UTSW)Verified postcodeDallas, United States
- University of Texas Health Science Center San Antonio (UTHSCSA)Verified postcodeSan Antonio, United States
Common questions
What is ALS?
ALS (Amyotrophic Lateral Sclerosis) is a serious illness affecting the nerve cells that control your muscles. It's also known as Motor Neurone Disease in the UK. Over time, it causes muscles to weaken.
What is a 'biomarker'?
A biomarker is like a special sign in your body, often found in blood or other body fluids, that can tell doctors more about a disease or how it is responding to treatment. They are very helpful for research.
Will this study give me a new treatment?
No, this study is about understanding the diseases better and finding biomarkers, rather than testing a specific new treatment. It's more about discovery for future treatments.
What is the difference between 'familial' and 'sporadic' forms of the disease?
'Familial' means the condition tends to run in families, suggesting a genetic link. 'Sporadic' means the condition occurs without a clear family history.
Do I have to do all the tests mentioned?
The study team will explain what's involved and discuss what you are comfortable with. You will need to agree to the procedures when you join.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.